Royalty Pharma
Venture capital · New York, New York, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio1 active
4Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Scholar Rock
12Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Arrowhead Pharmaceuticals | Biotech | Active | — | — |
| Scholar Rock | Biotech | Public | Jan 4, 2016 | $36.3M |
| Biohaven Pharmaceutical | Biotech | Public | — | — |
| Karuna Therapeutics | Biotech | Acquired | — | — |
| Vertex Pharmaceuticals | Biotech | Public | — | — |
Peer ranks
Portfolio size#81
Portfolio exits#49
Raises, 12 months#88
Co-investors#150
Co-investors
- Omega FundsVenture capital2 shared
- Third Rock VenturesVenture capital2 shared
- Bristol-Myers SquibbVenture capital1 shared
- Connecticut InnovationsVenture capital1 shared
- Deerfield Capital ManagementVenture capital1 shared
- HealthCare Royalty PartnersVenture capital1 shared
- Ionis PharmaceuticalsVenture capital1 shared
- Lux CapitalVenture capital1 shared
- OrbiMedVenture capital1 shared
- PureTech HealthVenture capital1 shared
Sectors
- Biotech5
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.